Oncology Pharma Inc.
ONPH
$0.0001
$0.000.00%
OTC PK
| 12/31/2004 | 09/30/2004 | 06/30/2004 | 03/31/2004 | 12/31/2003 | |
|---|---|---|---|---|---|
| Net Income | 84.66% | 96.58% | 52.02% | -26.63% | 3.47% |
| Total Depreciation and Amortization | -- | -- | -- | -86.36% | -78.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -100.00% | -- | -213.11% | -100.00% |
| Change in Net Operating Assets | -100.00% | 105.17% | -59.46% | -895.83% | 406.25% |
| Cash from Operations | 82.31% | 99.83% | 67.41% | -30,000.00% | 0.87% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 6,550.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 6,550.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,540.00% | -100.00% | -- | 8,400.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.86% | 99.50% | 98.15% | -7,700.00% | 0.43% |